ConductScience.org, home
HCCLM3
API referenceFor AI assistants

Cell line · CVCL_6832

Papers33

1 to 20 of 33

Download this page as JSON
PaperJournalYearHow we knowRetractedSource
USP4-Dependent CHAF1B Stabilization Regulates Distinct SETDB1 Ubiquitin States Linked to AKT T308 Signaling and Lipogenic Remodeling in HCC.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
FKBP52 dictates the dual role of p53 in hepatocellular carcinoma: Mutation-specific prognostic stratification and therapeutic implications.J Biol Chem2026Its Methods give the RRID and name the linePubMed
Targeting Cuproptosis and Ferroptosis via a ROS-Responsive Nanoplatform for Enhanced Synergistic Therapy Against Hepatocellular Carcinoma.Antioxidants (Basel)2026Its Methods give the RRID and name the linePubMed
The miR-4512/PDZK1IP1 axis in hepatocellular carcinoma: clinical significance, diagnostic value, and functional validation.BMC Med Genomics2026Its Methods give the RRID and name the linePubMed
CCT2 Orchestrates Glycolysis and Exosome-Mediated M2 Macrophage Polarization in HCC tumorigenesis.Int J Biol Sci2026Its Methods give the RRID and name the linePubMed
Ginkgolic acid targets HSPA8 to trigger ferroptosis in hepatocellular carcinoma via chaperone-mediated autophagy-dependent GPX4 degradation.Pharm Biol2026Its Methods give the RRID and name the linePubMed
β-catenin mutation reprograms ketone body metabolism to drive hepatocellular carcinoma metastasis and resistance to ketogenic therapy via transcriptional activation of OXCT1.Cell Death Dis2026Its Methods give the RRID and name the linePubMed
USP1 promotes hepatocellular carcinoma progression by modulating mitophagy via stabilizing MCM3 to regulate the Keap1-Nrf2 axis.iScience2026Its Methods give the RRID and name the linePubMed
RASGEF1B suppresses hepatocellular carcinoma through the ALDH7A1/Betaine/SNAI1 metabolic‒epigenetic axis.J Transl Med2026Its Methods give the RRID and name the linePubMed
PFKL Inhibition by DT-13: A Novel Approach to Combat Hepatocellular Carcinoma.Int J Hepatol2025Its Methods give the RRID and name the linePubMed
GSTK1 suppresses HCC aggravation via L-carnitine metabolism by PGAM5/DRP1 complex-mediated mitochondrial quality control.J Exp Clin Cancer Res2025Its Methods give the RRID and name the linePubMed
The LUBAC subunit HOIL-1 promotes the progression of HBV-associated hepatocellular carcinoma independently of linear ubiquitination.Exp Mol Med2025Its Methods give the RRID and name the linePubMed
Anti-Hepatocellular Carcinoma Effect of Jianpi Huayu Formula: Revealing the Molecular Mechanisms of the CXCR4 - Smad2/3 Pathway in Regulating Vasculogenic Mimicry Formation and Epithelial-Mesenchymal Transition.
Integr Cancer Ther2025Its Methods give the RRID and name the linePubMed
CD24 recruits tumor-associated neutrophils to promote the progression of hepatocellular carcinoma.J Immunother Cancer2025Its Methods give the RRID and name the linePubMed
Re-evaluation of the relationship between PrPc expression and patient prognosis in primary esophageal squamous cell carcinoma and primary hepatocellular carcinoma.Sci Rep2024Its Methods give the RRID and name the linePubMed
SIGLEC15, negatively correlated with PD-L1 in HCC, could induce CD8+ T cell apoptosis to promote immune evasion.Oncoimmunology2024Its Methods give the RRID and name the linePubMed
Chemically engineered mTOR-nanoparticle blockers enhance antitumour efficacy.EBioMedicine2024Its Methods give the RRID and name the linePubMed
NIR-II fluorescence-guided liver cancer surgery by a small molecular HDAC6 targeting probe.EBioMedicine2023Its Methods give the RRID and name the linePubMed
The Role of miR-1183: A Potential Suppressor in Hepatocellular Carcinoma via Regulating Splicing Factor SRSF1.J Hepatocell Carcinoma2023Its Methods give the RRID and name the linePubMed
A nanotherapeutic strategy that engages cytotoxic and immunosuppressive activities for the treatment of cancer recurrence following organ transplantation.EBioMedicine2023Its Methods give the RRID and name the linePubMed

cell-lines-2026-11-14-0.1.0

Next page

Sources 4

  • CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
  • PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
  • NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
  • PubMedNLM's terms
Each source's terms
  • CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
  • PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
  • NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
  • PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_6832/papers

API referenceFor AI assistants